フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
M TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in...
M Summit Therapeutics plc ("Summit Therapeutics" or the "Company") Notification of Transactions of Persons Discharging...
M Summit Therapeutics plc ('Summit' or the 'Company') Summit Therapeutics Launches Online Resource for Patients with C...
M TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of...
Summit Therapeutics PLC on Tuesday said it has completed a subscription and placing of new shares and warrants, raisi ...
M Summit Therapeutics plc ("Summit Therapeutics" or the "Company") Completion of $50 million Subscription and Placing and...
M Summit Therapeutics plc ('Summit' or the 'Company') Award of Share Options Oxford, UK, and Cambridge, MA, US, 24 December...
M Summit Therapeutics plc ('Summit' or the 'Company') Exercise of Restricted Stock Units Oxford, UK, and Cambridge, MA, US, 24...
M Summit Therapeutics plc ("Summit Therapeutics" or the "Company") Result of General Meeting, Admission of Fundraising Shares...
M Summit Therapeutics plc ("Summit Therapeutics" or the "Company") Timetable update for the proposed Subscription and Placing...
Summit Therapeutics PLC said Tuesday its revenue decreased for the three months ended October 31. The antibiotic de ...
M Summit Therapeutics plc ('Summit', the 'Company' or the 'Group') Summit Therapeutics Reports Financial Results and...
M Summit Therapeutics plc ('Summit' or the 'Company') Summit Therapeutics to Report Financial Results for the Third Quarter...
Antibiotics developer Summit Therapeutics PLC on Friday announced plans to raise significant cash, switch up the boar ...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約